Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
DLA CIO: Securing AI Pipelines Is Now a Core Mission
With small vendors comprising most of its supplier base, Roberts says stronger oversight and zero-trust controls are critical to counter cyber threats.
6m watch -
What New Guidance Says For Securing Agentic AI Systems
A multinational report outlines cybersecurity threats and best practices for deploying autonomous AI agents securely.
4m read -
Health IT Leaders Eye AI, Data Sharing to Improve Affordability
Healthy policy leaders say smarter data use, streamlined workflows and transparent AI tools could help lower costs and improve patient care.
3m read -
Pentagon Lab Review Targets Bureaucratic Barriers to Military Tech
Defense officials say the review aims to better integrate labs, speed testing and move capabilities to warfighters faster.
3m read
